J&J | JNJ - Operating Expenses


J&J reported $17.44B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AbbVie USD 10.27B 538M Mar/2026
Abbott USD 9.31B 104M Mar/2026
Amgen USD 4.78B 1.12B Mar/2026
AstraZeneca USD 8.18B 4.35B Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Bayer EUR 9.88B 452M Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Biogen USD 1.96B 69.6M Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Bristol-Myers Squibb USD 20.07B 11.77B Mar/2026
CONMED USD 291.63M 44.94M Mar/2026
Cooper Companies USD 1.11B 301.2M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Eli Lilly USD 10.02B 285M Mar/2026
Gilead Sciences USD 23.52B 18.55B Mar/2026
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Merck USD 18.17B 8.01B Mar/2026
Merit Medical Systems USD 337.72M 2.02M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Pfizer USD 90.1B 77.19B Mar/2026
Regeneron Pharmaceuticals USD 31.42B 28.44B Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
Stryker USD 4.92B 284M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teva Pharmaceutical Industries USD 3.22B 1000M Mar/2026
Vertex Pharmaceuticals USD 1.85B 78.6M Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026
Zoetis USD 3.23B 1.68B Mar/2026